EP0186023A2 — Biliary acid derivatives, process for their preparation and pharmaceutical compositions containing them
Assigned to Lehner AG · Expires 1986-07-02 · 40y expired
What this patent protects
Compounds of general formula (I) <CHEM> wherein: R is hydrogen, methyl or ethyl; R1 is a C1-C3 alkoxy group and, when R is ethyl, R1 may also be hydrogen or hydroxy; R2 and R3, which may be the same or different, represent hydroxy groups both of alpha and beta configu…
USPTO Abstract
Compounds of general formula (I) <CHEM> wherein: R is hydrogen, methyl or ethyl; R1 is a C1-C3 alkoxy group and, when R is ethyl, R1 may also be hydrogen or hydroxy; R2 and R3, which may be the same or different, represent hydroxy groups both of alpha and beta configuration, or keto groups. Compounds I are useful in therapy.
Drugs covered by this patent
- Ocaliva (OBETICHOLIC ACID) · Intercept Pharms Inc
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.